Christopher Patusky, Director at UNITED THERAPEUTICS Corp (UTHR), sold 9,600 shares at $309.73 ($3.0M) on 2025-03-19, disclosed to the SEC on 2025-03-20.
Scheduled sale ($3.0M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $307.73 | 300 | $92K | 3.1% |
| 2 | $308.82 | 1,780 | $550K | 18.4% |
| 3 | $308.82 | 1,780 | $550K | 18.4% |
| 4 | $309.73 | 328 | $102K | 3.4% |
| 5 | $309.73 | 328 | $102K | 3.4% |
| 6 | $310.80 | 457 |
| $142K |
| 4.8% |
| 7 | $310.80 | 457 | $142K | 4.8% |
| 8 | $312.22 | 736 | $230K | 7.7% |
| 9 | $312.22 | 736 | $230K | 7.7% |
| 10 | $313.14 | 1,299 | $407K | 13.6% |
| 11 | $313.14 | 1,299 | $407K | 13.6% |
| 12 | $313.77 | 100 | $31K | 1.1% |
| Total | $310.78 avg | 9,600 | $3.0M | 100% |
| Filing → |
| UTHR | SELL | 2025-12-16 | $496K | — | Filing → |
| UTHR | SELL | 2025-01-13 | $3.3M | — | Filing → |
| UTHR | SELL | 2024-09-05 | $1.8M | — | Filing → |